The new data, published this week in JAMA Network Open, show that after adjusting for multiple variables, COVID-19 patients treated with ACE inhibitors and ARBs had a significantly lower risk of death ...

Research has shown that angiotensin converting enzyme (ACE) inhibitors help manage diabetic nephropathy-related issues. They can also slow the progression of diabetic nephropathy in some people.

(UPDATED) Hospitalized patients with COVID-19 who continue on their previously prescribed ACE inhibitors and ARBs are not at an increased risk of dying or remaining in the hospital when compared to ...

ACE inhibitors that can cross the blood-brain barrier may help prevent dementia, according to findings presented at the American Geriatrics Society meeting in Seattle in May. Using data from a larger, ...

Please provide your email address to receive an email when new articles are posted on . Drug classes used as monotherapy for hypertension were shown to be comparable, although thiazide or ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Here are the coronavirus stories Medscape's editors around the globe think you need to know about ...

An angiotensin-converting-enzyme (ACE) inhibitor, the most common first-line approach for newly diagnosed hypertension, is not as effective and causes more adverse effects than a thiazide diuretic, a ...

DALLAS, Aug. 17 – Iron supplements may be a simple remedy for the “common cough” associated with a widely used cardiovascular drug, according to a study in this month’s Hypertension: Journal of the ...